Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Jun 18, 2020 10:45pm

100 Views

Post# 31167705

RE:RE:RE:RE:RE:THTX

The stocktwits posting reads similar to the things SPCEO posts ... do you know who posted it?

-LT

scarlet1967 wrote:

scarlet1967 wrote:

qwerty22 wrote:
Those links go to the wrong page.

scarlet1967 wrote:

scarlet1967 wrote: There is a second page on Stocktwits.

https://stocktwits.com/BullFisher07/message/221138949

Best to go to the site directly for whatever reason I can't copy and past it.
Basically it seems like Thera might even consider the general Nash now, worth checking it out.